Vaccines Are Good Business for Drug Makers
66884
Some have explained the flu vaccine shortage by saying that the vaccines business holds little allure, but vaccines, it turns out, can make for good business.
140691
At a time when the drug industry is being pounded with recalls and government investigations while turning out few major new drugs, French drugmaker Sanofi-Aventis appears to have a big winner on its hands.
10738
A partnership deal has investors in the small specialty pharma excited.
673302
TRENTON, N.J. -- Pediatricians, gynecologists and even health insurers all call Gardasil, the first vaccine to prevent cervical cancer, a big medical advance.
603104
ID Biomedical (Nasdaq: IDBE) recently showed the importance of being in the right place at the right time, especially in the vaccine business.
505962
Cephalon gets some good news about its drug PROVIGIL.
276263
Pharmaceutical company GlaxoSmithKline PLC has agreed to donate 50 million doses of H5N1 vaccine to the World Health Organization in an attempt to create a pandemic vaccine stockpile for poor countries, company officials announced Wednesday.
288137
The sudden, major flu vaccine shortage that shocked health authorities last week highlights two vulnerabilities in the nation&#39;s immunization system: a reliance on a few private manufacturers that use old technology, and government&#39;s faith that companies
695605
Pharmaceutical companies have profited from medicines derived from spiders. Now a group called Venom Venture is making sure some of that money goes toward conserving the spiders themselves.
239493
The shortage of flu vaccines this season should serve as a wake-up call about the serious challenges facing the vaccine business and the resulting threat to public health.
186865
ID Biomedical Corp. signed long-term agreements with three of the largest US flu vaccine wholesalers, causing the firmâs shares to climb 9.2 percent.
521788
GlaxoSmithKline's cervical cancer vaccine gets a positive recommendation.
219858
In the midst of the United States&#39; flu vaccine shortage, two studies have shown that the jab could still work at a fraction of its normal strength.
710477
British pharmaceutical group GlaxoSmithKline has said that its net profit jumped by 12.4 percent in the second quarter of 2006, after reporting a &quot;breakthrough&quot; in the development of a vaccine to protect humans against the H5N1 strain of bird flu.
358806
GlaxoSmithKline may be able to produce a vaccine in mass quantities to protect humans from bird flu by next year, the drugmaker said Wednesday following encouraging results from a clinical trial.
733152
French drugmaker Sanofi-Aventis has won U.S. approval to sell a new vaccine designed to give longer protection against meningitis, a potentially fatal bacterial infection.
607958
A vaccine that could prevent young women  from developing most cases of cervical cancer could be on the  market within a few years.